Abstract
Cardiovascular complications occur frequently in patients with renal disease. Furthermore, cardiovascular derangements constitute the leading cause of death in the population with end-stage renal failure on chronic dialysis (1,2). Prevention and treatment of cardiovascular disorders is therefore of major importance in these patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Bryan F Jr: National Registry Report. Proc 6th Ann Contractors Conference. Artificial Kidney Program. NIAMDD. DHEW Publ No (NIH) 74–248:201–207, 1973.
Parsons FM, Brunner FP, et al.: Combined report regular dialysis and transplantation in Europe II, Dialysis and renal transplantation. Proceedings of the Eight Conference, Berline, Vol 8. Pitman Medical, London, pp3–27, 1971.
Lazarus JM, Hampers CL, Merrill JP: Hypertension in chronic renal failure. Treatment with hemodialysis and nephrectomy. Arch Intern Med 133:1059–1066, 1974.
Vincenti F, Amend JW, Abele J, et al.: The role of hypertension in hemodialysis-associated atherosclerosis. Am J Med 68:363–369, 1980.
Ayus JC, Frommer P, Olivero JJ, et al.: Effect of long-term dialysis on left ventricular ejection fraction in end-stage renal disease. Kidney Int 19:142A, 1981.
Terman DS, Alfrey AC, Hammond WS, et al.: Cardiac calcification in uremia: A clinical, biochemical and pathologic study. Am J Med 50:744, 1971.
Drueke T, Fauchet M, Fleury J, et al.: Effect of parathyroidectomy on left ventricular function in haemodialysis patients. Lancet 1:112–114, 1980.
Bogin E, Massry SG, Harary I: Effect of parathyroid hormone on heart cells. J Clin Invest 67:1215–1227, 1981.
London GM, Fabiani F, Marchais SJ, et al.: Uremic cardiomyopathy: An inadequate left ventricular hypertrophy. Kidney Int 31:973–980, 1987.
Lindner A, Charra B, Sherrard DJ, et al.: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290:697–701, 1974.
Wacker W, Merrill JP: Uremic pericarditis in acute and chronic renal failure. JAMA 156:764–765, 1954.
Bailey GL, Hampers CL, Hager EB, Merrill JP: Uremic pericarditis: Clinical features and management. Circulation 38:582–591, 1968.
Comty CM, Cohen SL, Shapiro FL: Pericarditis in chronic uremia and its sequels. An Intern Med 75:173–183, 1971.
Ribot S, Frankel JH, Gielchincky I, et al.: Treatment of uremic pericarditis. Clin Nephrol 2:127–130, 1974.
Comty CM, Wathen R, Shapiro FL: Incidence, mortality and effects of treatment on uremic pericarditis. Am Soc Nephrol 8:28, 1975.
Wray TM, Stone WJ: Uremic pericarditis: A prospective echocardiographic and clinical study. Clin Nephrol 6:295–302, 1976.
Frommer JP, Young JB, Ayus JC: Asymptomatic pericardial effusion in uremic patients: Effect of long-term dialysis. Nephron 39:296–301, 1985.
Lazarus JM, Gottlieb MN, Lowrie EG, et al.: Echocardiographic findings in stable hemodialysis patients. Proc Dialysis Transplant Forum 6:53–57, 1976.
Horton JD, Gelfand MC, Sherber HS. Natural history of asymptomatic pericardial effusions in patients on maintenance hemodialysis. Proc Dialysis Transplant Forum 7:76–78, 1977.
Renfrew RM Busselmeier TJ, Kjellstrand CM: Pericarditis and renal failure. Ann Rev Med 31:345–360, 1980.
Ayus JC, Frommer JP, Young JB: Cardiac and circulatory abnormalities in chronic renal failure. Semin Nephrol 1:112–123, 1981.
Comty CM, Shapiro FL: Cardiac complications of regular dialysis treatment. In: W Drukker, FM Parsons, JF Maher, eds, Replacement of Renal Function by Dialysis. Martinus Nihjoff The Hague, pp 519–537, 1978.
Markiewicz W, Brik A, Brook G, et al.: Pericardial rub in pericardial effusion: Lack of correlation with with amount of fluid. Chest 77:643–646, 1980.
Yoshida K, Shiina A, Asano Y, et al.: Uremic pericardial effusion: Detection and evaluation of pericardial effusion by echocardiography. Clin Nephrol 13:260–268, 1980.
Marini PV, Hull AR: Uremic pericarditis: A review of incidence and management. Kidney Int 7(1)11:163–166, 1975.
Silverberg S, Oreopoulos DG, Wise DJ, et al.: Pericarditis in patients undergoing long-term hemodialysis and peritoneal dialysis. Incidence, complications and management. Am J Med 63:874–880, 1977.
Cohen GF, Burgess JH, Kaye M: Peritoneal dialysis for the treatment of pericarditis in patients on chronic hemodialysis. Can Med Assoc J 102:1365–1368, 1970.
Alfrey AC, Goss JE, Ogden DA, et al.: Uremic hemoperi-cardium. Am J Med 45:391–400, 1970.
Skov PE, Hansen HE, Spencer ES: Uremic pericarditis. Acta Med Scand 186:421–428, 1969.
Mitchell AG: Pericarditis during chronic hemodialysis therapy. Postgrad Med J 50:741–745, 1974.
Gulyassy PF, Yamauchi H, Depner TA: Conservative management of renal failure. In: LE Early, CW Gottschalk, eds, Diseases of the Kidney, Strauss and Welt. Little, Brown, Boston, Chapter 11, 1979.
Minuth ANW, Nottebohm GA, Eknoyan G, et al.: In-domethacin treatment of pericarditis in chronic hemodialysis patients. Arch Intern Med 135:807–810, 1975.
Spector D, Alfred H, Siedlecki M, et al.: A controlled study of the effect of indomethacin in uremic pericarditis. Kidney Int 24:663, 1983.
Tan SY, Shapiro R, Franco R, et al.: Indomethacin-induced prostaglandin inhibition with hyperkalemia. A reversible cause of hyporeninemic hypoaldosteronism. Ann Int Med 90:783–785, 1979.
Feinroth MV, Goldstein EJC, Josephson A, et al.: Infection complicating intrapericardial steroid instillation in uremic pericarditis. Clin Nephrol 15:331, 1981.
Buselmeier TJ, Davin TD, Simmons RL, et al.: Treatment of intractable uremic pericardial effusion. Avoidance of pericardiectomy with local steroid instillation. JAMA 240:1358–1359, 1978.
Ghavamian M, Gutch CF, Hughes RK, et al.: Pericardial tamponade in chronic hemodialysis patients. Treatment by pericardiectomy. Arch Intern Med 131:249–253, 1973.
Ali-Regiaba S, Gay WA, Sullivan JF, et al.: Treatment of uraemic pericarditis by anterior pericardiectomy. Lancet 2:12–14, 1974.
Singh S, Newmark K, Ishikawa I, et al.: Pericardiectomy in uremia. The treatment of choice for cardiac tamponade in chronic renal failure. JAMA 228:1132–1135, 1974.
Morin JE, Mulder DS, Long R: Pericardiectomy for uremic tamponade. Can J Surg 19:109–112, 1976.
Connors JP, Kleiger RE, Shaw RC, et al.: The indications for pericardiectomy in the uremic pericardial effusion. Surgery 80:689–694, 1976.
Engelman RM, Levitsky S, Konchigeri HN, et al.: Total pericardiectomy for uremic pericarditis. World J Surg 1:769–776, 1977.
Morin JE, Hollomby D, Gonda A, et al.: Management of uremic pericarditis: A report of 11 patients with cardiac tamponade and a review of the literature. Ann Thorac Surg 22:588–592, 1976.
Goldstein DH, Nagar C, Srivastava N, et al.: Clinically silent pericardial effusion in patients on long-term hemodialysis. Pericardial effusions in hemodialysis. Chest 72:744–747, 1977.
Cruz IA, Bhatt GR, Cohen HC, et al.: Echocardiographic detection of cardiac involvement in patients with chronic renal failure. Arch Intern Med 138:720–724, 1978.
Schott CR, LeSar JF, Kotler MN, et al.: The spectrum of echocardiographic findings in chronic renal failure. Cardiovasc Med 3(2):217–227, 1978.
Payne RM, Soderblom RE, Lobstein PH, et al.: Exercise-induced hemodynamic effects of arterio-venous fistulas used for hemodialysis. Kidney Int 2:344–348, 1972.
Anderson CB, Cod JR, Graff GM, et al.: Cardiac failure and upper extremity arterio-venous dialysis fistulas. Arch Intern Med 136:292–297, 1976.
Ahearn DH, Maher JF: Heart failure as a complication of a hemodialysis arteriovenous fistula. Ann Intern Med 77:201–204, 1972.
Burke JF, Francos GC, Moore LL, et al.: Accelerated atherosclerosis in chronic dialysis patients: Another look. Nephron 21:181–185, 1978.
Bailey GL, Hampers CL, Merrill JP: Reversible cardiomyopathy in uremia. Trans Am Soc Artif Intern Organs 13:263–272, 1967.
Ianhez LE, Lowen J, Sabbaga E: Uremic myocardiopathy. Nephron 15:17–28, 1975.
Nivatpumin T, Yipintsoi T, Penpargkul S, et al.: Increased cardiac contractility in acute uremia. Interrelationships with hypertension. Am J Physiol 229:501–505, 1975.
Scheuer J, Sterzoski SW: The effects of uremic compounds on cardiac function and metabolism. J Mol Cell Cardiol 5:287–300, 1973.
Kersting F, Brass H, Heintz R: Uremic cardiomyopathy: Studies on cardiac function in the guinea pig. Clin Nephrol 10:109–113, 1978.
Penpargukul S, Scheuer J: Effect of uraemia upon the performance of the rat heart. Cardiovasc Res 6:702–708, 1972.
Raab W: Cardiotoxic substances in the blood and heart muscle in uremia (their nature and action). J Lab Clin Med 29:725–734, 1944.
Knowlan DM, Piatnek DA, Olson RE: Myocardial metabolism and cardiac output in acute uremia. Clin Res 9:141, 1961.
Bernard P, Crest M, Rianado J, et al.: A study of the cardiotoxicity of uremic middle molecules on embryonic chick hearts. Nephron 31:135, 1982.
Lee JC, Downing SE: Negative inotropic effects of phenol on isolated cardiac muscle. Am J Path 102:367, 1981.
Pehrsson SK, Lins LE: The role of trace elements in uremic heart failure. Nephron 34:93, 1983.
Fernando HA, Friedman HS, Zaman Q, et al.: Echocardiographic assessment of cardiac performance in patients in maintenance hemodialysis. Cardiovasc Med 4:459–471, 1979.
Vaziri ND, Prakash R: Echocardiographic evaluation of the effect of hemodialysis on cardiac size and function in patients with end-stage renal disease. Am J Med Sci 278:201–206, 1979.
Hung J, Harris PJ, Uren RF, et al.: Uremic cardiomyopathy: Effect of hemodialysis on left ventricular function in end-stage renal failure. N Engl J Med 302:547–551, 1980.
Henrich WL, Hung J, Nixon JV: Increased ionized calcium and left ventricular contractitity during hemodialysis. N Engl J Med 310, 1984.
Ruder MA, Alpert MA, Van Stone J: Comparative effects of acetate and bicarbonate hemodialysis on left ventricular function. Kidney Int 27:768–773, 1985.
Aljama P, Martin-Malo A, Sanz R, et al.: Left ventricular function during haemofiltration and haemodialysis: A comparative study. Proc Eur Dial Travpl Assoc 19:281, 1982.
Cini G, Camici M, Pentimone F, Palia R: Echocardiographic hemodynamic study during ultrafiltration sequential dialysis. Nephron 30:124, 1982.
Brunner FP, Gurland HJ, Harlen H, Schafer K, Parsons RM: Combined report on regular dialysis and transplantation in Europe, II, 1971. Proc Eur Dial Transpl Assoc 9:34, 1972.
Siddiqui JY, Fitz AE, Lawton RL, Kirkendall WN: Causes of death in patients receiving long-term hemodialysis. JAMA 212:1350–1354, 1970.
Vereerstraeten P: La survie du Brightique traite par l’hemo-dialyse. S Sc Med Lille, 88:49, 1970.
Cutler SS, Wolf J: Acquired arteriovenous fistula with coexistant subacute bacterial endocarditis and endoarteritis. Ann Int Med 25:972–981, 1946.
Hook EW, Wainer HS, McGee TJ, Sellers TF: Acquired arteriovenous fistula with bacterial endoarteritis and endocarditis. JAMA 164:1450–1454, 1957.
Lee SH, Fisher B, Fisher ER, Little A: Arteriovenous fistula and bacterial endocarditis. Surgery 52:463–467, 1982.
Brecia MJ, Cimino JE, Appel K, Hurwitz BJ: Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med 275:1089–1092, 1966.
Leonard A, Raij L, Shapiro FL: Bacterial endocarditis in regularly dialyzed patients. Kidney Int 4:407–422, 1973.
King LH, Bradley KP, Shires DL, Donohue JP, Glover JL: Bacterial endocarditis in chronic hemodialysis patients: A complication more common than previously suspected. Surgery 69:554–556, 1971.
Kuruvila KC, Beven EG: Arteriovenous shunts and fistulas for hemodialysis. Surg Clin North Am 51:1219–1234, 1971.
Wilson WEC, Kirkpatrick CH, Talmage DW: Suppression of immunologic responsiveness in uremia. Ann Intern Med 62:1–13, 1965.
Lillehei CW, Bobb JRR, Visscher MB: Occurrence of endocarditis with valvular deformities in dogs with arteriovenous fistulae. Proc Soc Exp Biol Med 75:9–16, 1950.
Rodbard S: Blood velocity and endocarditis. Circulation 27:18, 1963.
Cross AS, Steigbigel RT: Infective endocarditis and access site infections in paitents on hemodialysis. Medicine 55:453–466, 1976.
Gantz NM, Myerwitz RL, Medoiros AA, Camera GF, Wilson RE, O’Brien TF: Listeriosis in immunosuppressed patients: A cluster of eight cases. Am J Med 58:637–643, 1975.
Pendras JP, Smith MP: The silastic-Teflon arteriovenous cannula. Trans Am Soc Artif Intern Organs 12:222–228, 1966.
Ralston AJ, Harlow GR, Jones DM, Davis P: Infections of Scribner and Brescia arterio-venous shunts. Br Med J 3:408–409, 1971.
Levi J, Robson M, Rosenfeld JB: Septicemia and pulmonary embolism complicating use of arteriovenous fistula in maintenance haemodialysis. Lancet 2:288–290, 1970.
Garvey GJ, Neu HC: Infective endocarditis — an evolving disease. Medicine 57:105–127, 1978.
Morris AJ, Bilinsky RT: Prevention of staphylococcal shunt infections by continuous vancomycin prophylaxis. Am J Med Sci 262:87–91, 1971.
Martin AM, Clunie GJA, Tonkin RW, Robson JS: The aetiology and management of shunt infections in patients in intermittent hemodialysis, dialysis, and renal transplantation. Proc Eur Dial Transplant Assoc 4:67, 1967.
Bisno AL, Dismukes WE, Durack DT, et al.: Treatment of infective endocarditis due to Viridans streptococci. Council on Cardiovascular Disease in the Young. Ad Hoc Subcommittee on Treatment of Bacterial Endocarditis. Circulation 63:733A, 1981.
Bennett W, Muther RS, Parker R, et al.: A guide to drug therapy in renal failure. Ann Int Med 93:62–99, 1980.
Calderwood SB, Moellering RC: Common adverse effects of antimicrobial agents on major organ systems. Surg Clin North Am 60:65–81, 1980.
Watanakunakorn C, Glotzbecker C: Enhancement of the effects of anti-staphylococcal antibiotics by aminoglycosides. Antimicrob Agents Chemother 6:802–806, 1974.
Bryan CS, Stone WJ: “Comparably massive” penicillin G therapy in renal failure. Ann Int Med 82:189–195, 1975.
Cutler RE, Gyselynck AM, Fleet WP, Forrey AW: Correlation of serum creatinine concentration and gentamycin shelf life. JAMA 219:1037–1041, 1972.
Chan RA, Benner EJ, Hoeprich PD: Gentamycin therapy in renal failure: A nomogram for dosage. Ann Int Med 76:773–778, 1972.
Ayus JC, Eneas FJ, Tong TG, et al.: Peritoneal clearance and total body elimination of vancomycin during chronic intermittent peritoneal dialysis. Clin Nephrol 11(3): 129–132, 1979.
Lindholm DD, Murray JS: Persistence of vancomycin in the blood during renal failure and its treatment of hemodialysis. N Engl J Med 274:1047–1051, 1966.
Krothapalli PK, Senekjian HO, Ayus JC: Efficacy of intravenous vancomycin in the treatment of grampositive peritonitis in long-term peritoneal dialysis. Am J Med 75:345–348, 1983.
Dtinson EB: Surgical treatment of infective endocarditis. Progr Cardiovasc Dis 22:145–168, 1979
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Kluwer Academic Publishers
About this chapter
Cite this chapter
Ayus, J.C., Krothapalli, R.K. (1991). Cardiovascular Complications of Uremia and Dialysis. In: Suki, W.N., Massry, S.G. (eds) Therapy of Renal Diseases and Related Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0689-4_45
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0689-4_45
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8027-9
Online ISBN: 978-1-4613-0689-4
eBook Packages: Springer Book Archive